Success Metrics

Clinical Success Rate

50.0%

Based on 3 completed trials

Completion Rate

50%(3/6)

Active Trials

0(0%)

Results Posted

133%(4 trials)

Terminated

3(38%)

Phase Distribution

Ph phase_1

13%

Ph not_applicable

13%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

6(75.0%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(4)

Other(1)

Detailed Status

Completed3

Terminated3

Withdrawn1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (12.5%)

Phase 26 (75.0%)

N/A1 (12.5%)

Trials by Status

withdrawn113%

completed338%

terminated338%

unknown113%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_1

Optimal Selenium for Bowel Polyps (OSCAR)

NCT04952129

completedphase_2

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

NCT00736645

terminatedphase_2

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00526890

terminatedphase_2

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

NCT00625183

completednot_applicable

Influence of Selenium on Prostate Cancer Related Biomarkers

NCT01112449

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT04952129Phase 1

Optimal Selenium for Bowel Polyps (OSCAR)

Completed

NCT00736645Phase 2

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Completed

NCT00526890Phase 2

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Terminated

NCT00625183Phase 2

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Terminated

NCT01112449Not Applicable

Influence of Selenium on Prostate Cancer Related Biomarkers

Completed

NCT02302768Phase 2

Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

Unknown

NCT01682031Phase 2

Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

Terminated

NCT00736164Phase 2

Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer